You are a medical innovator with a new idea that can change lives.
Advancing new medical technologies is challenging. We make it easier, so you can focus on breakthroughs, not barriers.
Our Clients










We support innovators
from idea to exit
Clinicians, researchers, and innovators sometimes struggle to turn ideas into tangible impact for patients’ lives. We guide you through the complexities of the medical innovation landscape, turning your idea into market-ready product that improve patient care and healthcare delivery.

We help you get new medical ideas to market.
We meet you where you are and help you along the journey.
We have helped hundreds of innovators demystify the path to success.
Testimonials
What people are saying
Who We Are
Managing Partner

Manuel is an expert in technology innovation and commercialization, with a proven track record of helping businesses enter new markets and develop effective growth strategies. Specializing in business development and executing mergers and acquisitions, Manuel has successfully guided organizations through high-impact deals. He also excels at engaging investors and strategic acquirers, ensuring the right partnerships for sustained success.
Managing Partner

Jissel is a seasoned leader with expertise in developing a shared vision and aligning organizations to achieve strategic goals. She excels in strategic and business planning, with a strong background in establishing and managing global PMOs. Jissel has successfully led major global initiatives, driving collaboration and operational excellence across diverse teams and markets.
Why should you wander in the dark when you have a valuable hidden gem in hand?
Let us guide you on your journey.
We met a medical innovator who has a small but successful business, providing a comprehensive physical evaluation to assess cardiovascular risk. This approach could be extremely impactful to the broader population. However, he insists on figuring out how to grow the business on his own and has been unable to scale after more than five years. His investors are frustrated, his board is frustrated, and the world is missing out on a valuable life-changing technology.